Browse > Article

Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis  

Zhao, Jian-Meng (The First Clinical Medical College of Lanzhou University)
Wang, Yong-Hong (The First Clinical Medical College of Lanzhou University)
Yao, Nan (The First Clinical Medical College of Lanzhou University)
Wei, Kong-Kong (The First Clinical Medical College of Lanzhou University)
Jiang, Lei (Department of General Surgery, the First Hospital of Lanzhou University)
Hanif, Shahbaz (The First Clinical Medical College of Lanzhou University)
Wang, Zi-Xia (The First Clinical Medical College of Lanzhou University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.17, no.9, 2016 , pp. 4295-4300 More about this Journal
Abstract
Background: Recently, several studies have reported that elevated platelet counts may be associated with the poor prognosis of colorectal cancer. However, conclusions remain controversial. This meta-analysis was therefore designed to analyze and evaluate the prognostic role of preoperative or pretreatment thrombocytosis in patients with colorectal cancer. Materials and Methods: We searched PubMed, EMBASE, the Cochrane Library and Web of Science to March 29th, 2015. The citation lists of included studies were also hand-searched to identify further relevant trials. To investigate the association between thrombocytosis and prognosis of colorectal cancer, the 1-year, 3-year and 5-year survival of each studies were obtained. The odds ratio (OR) with its 95% confidence interval (CI) was used to evaluate the relation of overall survival (OS) between thrombocytosis and normal platelet counts (PLT). Likewise, disease free survival (DFS) was obtained and evaluated. The analysis was performed and assessed using Review Manager 5.2. Results: A total of 14 studies (N=5,566 participants, 11 including 4,468 for OS, 6 including 1,533 for DFS) were included in this meta-analysis, of which seven (N=3810) defined thrombocytosis as a platelet count ${\geq}400{\times}10^9/L$, and 375 (9.8%) patients exhibited pretreatment thrombocytosis. Thrombocytosis have a close relationship with the poor OS of colorectal cancer compared with normal PLT, with the pooled ORs of 1-year, 3-year and 5-year survival being 0.41 [95% CI 0.34-0.51; P<0.001], 0.28 [95% CI 0.21-0.38; P<0.001] and 0.26 [95% CI 0.20-0.34; P<0.001], respectively. For DFS, the same results were showed as the pooled ORs of 1-year, 3-year and 5-year survival respectively being 0.34 [95% CI 0.24-0.50; P<0.001], 0.31 [95% CI 0.23-0.43; P<0.001] and 0.25 [95% CI 0.18-0.34; P<0.001]. Conclusions: This meta-analysis indicated that thrombocytosis may predict poor prognosis for patients with colorectal cancer, and platelet counts may be a cost-effective and noninvasive marker.
Keywords
Thrombocytosis; prognosis; colorectal cancer; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Xin-Ji Z, Yong-Gang L, Xiao-Jun S, et al (2015). The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis. Int J Surg, 21, 84-91.   DOI
2 Yu I, Chen L, Ruan JY, Chang JT, Cheung WY (2016). Risk and management of venous thromboembolisms in bevacizumabtreated metastatic colorectal cancer patients. Support Care Cancer, 24, 1199-208.   DOI
3 Yu M, Liu L, Zhang BL, et al (2012). Pretreatment thrombocytosis as a prognostic factor in women with gynecologic malignancies: a meta-analysis. Asian Pac J Cancer Prev, 13, 6077-81.   DOI
4 Zhang X and Ran Y (2015). Prognostic role of elevated platelet count in patients with lung cancer: a systematicreview and meta-analysis. Int J Clin Exp Med, 8, 5379-87.
5 Chen W, Zheng R, Zuo T, et al (2016). National cancer incidence and mortality in China, 2012. Chin J Cancer Res, 28, 1-11.
6 Alcindor T, et al (2008). Is the platelet count a pronostic factor in pancreas cancer and cholangiocarcinoma? Ann Oncol, 19, 185.
7 AlSaeed EF, et al (2015). Correlation of pretreatment hemoglobin and platelet counts with clinicopathological features in colorectal cancer in Saudi Population (vol 20, pg 134, 2014). Saudi J Gastroenterol, 21, 58.   DOI
8 Aranda E, Aparicio J, Alonso V, et al (2015). SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015. Clin Transl Oncol, 17, 972-81.   DOI
9 Campos Gomez S, et al (2014). Pretreatment platelets count levels as a prognostic factor in triple-negative breast cancer in a Hispanic cohort. J Clin Oncol, 32, 15.
10 Baranyai Z, Krzystanek M, Josa V, et al (2014). The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer. Thromb Haemost, 111, 483-90.   DOI
11 Canadian Cancer Society's Advisory Committee on Cancer Statistics (2013) Canadian Cancer Statistics 2013. http://www.cancer.ca//media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20 cancer%20 statistics/canadian-cancer-statistics-2013-EN.pdf. Accessed 10 Sept 2013.
12 Castillo-Perez JJ. (2013). Regarding the article "thrombocytosis as a predictor of distant recurrence in patients with rectal cancer". Arch Med Res, 44, 77-8.   DOI
13 Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K (2013). Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer, 109, 401-7.   DOI
14 Cravioto-Villanueva A, Luna-Perez P, Gutierrez-de la Barrera M, et al (2012). Thrombocytosis as a Predictor of Distant Recurrence in Patients with Rectal Cancer. Arch Med Res, 43, 305-11.   DOI
15 Gu ML, Yuan CJ, Liu XML, et al (2015). Pre-treatment Elevated Platelet Count Associates with HER2 Overexpression and Prognosis in Patients with Breast Cancer. Asian Pac J Cancer Prev, 16, 5537-40.   DOI
16 Guo T, Krzystanek M, Szallasi Z, Szallasi A (2014). Thrombocytosis portends adverse prognostic significance in patients with stage II colorectal carcinoma. F1000Research, 3, 180.
17 Higgins J and GS (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. www.cochranehandbook. org (18 March 2014, date last accessed).
18 Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K (2012). Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. J Surg Oncol, 106, 887-91.   DOI
19 Ilhan-Mutlu A, Starlinger P, Perkmann T, et al (2015). Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. Biomark Med, 9, 327-35.   DOI
20 Josa V, Krzystanek M, Eklund AC, et al (2015). Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer. Int J Surg, 18, 1-6.   DOI
21 Josa V, Krzystanek M, Vass T, et al (2015). Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor. Pathol Oncol Res, 21, 991-7.   DOI
22 Men H , Liang C, Yu M (2015). Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: a meta-analysis of literature. J Cancer Res Ther, 11, 67-72.   DOI
23 Kanavos P and Schurer W (2010). The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ, 10, 115-29.   DOI
24 Kandemir EG, Mayadagli A, Karagoz B, et al (2005). Prognostic significance of thrombocytosis in node-negative colon cancer. J Int Med Res, 33, 228-35.   DOI
25 Kawai K, Kitayama J, Tsuno NH, Sunami E, Watanabe T (2013). Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer. Int J Colorectal Dis, 28, 527-35.   DOI
26 Kisucka J, Butterfield CE, Duda DG, et al (2006). Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A, 103, 855-60.   DOI
27 Lin MS, Huang JX, Zhu J, Shen HZ. (2012). Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis. Hepatogastroenterology, 59, 1687-90.
28 Monreal M, Fernandez-Llamazares J, Pinol M, et al (1998). Platelet count and survival in patients with colorectal cancer - a preliminary study. Thromb Haemost, 79, 916-8.
29 Nieswandt B, Hafner M, Echtenacher B, Mannel DN (1999). Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res, 59, 1295-300.
30 Nyasavajjala SM, Runau F, Datta S, et al (2010). Is there a role for pre-operative thrombocytosis in the management of colorectal cancer? Int J Surg, 8, 436-38.   DOI
31 Padilla D, Cubo T, Pardo R, et al (2004). Preoperative platelet count and colorectal cancer recurrence. Rev Esp Enferm Dig, 96, 733-4.
32 Sasaki K, Kawai K, Tsuno NH, Sunami E, Kitayama J (2012). Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer. World JnSurg, 36, 192-200.   DOI
33 Peterson JE, Zurakowski D, Italiano JE Jr, et al (2012). VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis, 15, 265-73.   DOI
34 Qiu MZ, Yuan ZY, Luo HY, et al (2010). Impact of pretreatment hematologic profile on survival of colorectal cancer patients. Tumour Biol, 31, 255-60.   DOI
35 Review Manager (RevMan) [Computer Program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
36 Shwaiki A and Safar AM (2004) . The impact of platelet count (Plt#) on outcome in curable colon cancer. World J Surg, 22, 893S.
37 Suzuki K, Aiura K, Kitagou M, et al (2004). Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients. Hepatogastroenterology, 51, 847-53.
38 Toiyama Y, Inoue Y, Kawamura M, et al (2015). Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. Int Surg, 100, 199-207.   DOI
39 University of York Centre for Reviews and Dissemination. Systematic Reviews: CRD's Guidance for Undertaking Reviews in Health Care. York: CRD, University of York, 2009.
40 Wan S, Lai Y, Myers RE, et al (2013). Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer, 44, 293-304.   DOI
41 Wang C, Chen YG, Gao JL, et al (2015). Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model. Oncol Lett, 10, 754-60.   DOI